JANX

JANX

USD

Janux Therapeutics Inc. Common Stock

$27.010+0.240 (0.897%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$26.770

Máximo

$27.660

Mínimo

$26.330

Volumen

1.16M

Fundamentos de la Empresa

Capitalización de Mercado

1.6B

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.91M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $21.73Actual $27.010Máximo $71.71

Noticias Relacionadas

Analyst Upgrades

Barclays Initiates Coverage On Janux Therapeutics with Overweight Rating, Announces Price Target of $47

Barclays analyst Etzer Darout initiates coverage on Janux Therapeutics with a Overweight rating and announces Price Target of $47.

Ver más
Barclays Initiates Coverage On Janux Therapeutics with Overweight Rating, Announces Price Target of $47
Analyst Upgrades

Truist Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $100

Truist Securities analyst Asthika Goonewardene initiates coverage on Janux Therapeutics with a Buy rating and announces Price Target of $100.

Ver más
Truist Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $100
Analyst Upgrades

Stifel Reinstates Buy on Janux Therapeutics, Announces $45 Price Target

Stifel analyst Bradley Canino reinstates Janux Therapeutics with a Buy and announces $45 price target.

Ver más
Stifel Reinstates Buy on Janux Therapeutics, Announces $45 Price Target

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.